Pharma & Healthcare

Global Iopromide Injection Market Research Report 2025

Report Scope
This report aims to provide a comprehensive presentation of the global market for Iopromide Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iopromide Injection.
The Iopromide Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Iopromide Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iopromide Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bayer HealthCare
Brilliant Pharmaceutical
Segment by Type
150 mg I/mL
240 mg I/mL
300 mg I/mL
370 mg I/mL
Segment by Application
CT
Digital Subtraction Angiography
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iopromide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Iopromide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
1 Iopromide Injection Market Overview
1.1 Product Definition
1.2 Iopromide Injection by Type
1.2.1 Global Iopromide Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 150 mg I/mL
1.2.3 240 mg I/mL
1.2.4 300 mg I/mL
1.2.5 370 mg I/mL
1.3 Iopromide Injection by Application
1.3.1 Global Iopromide Injection Market Value by Application (2024 VS 2031)
1.3.2 CT
1.3.3 Digital Subtraction Angiography
1.3.4 Other
1.4 Global Iopromide Injection Market Size Estimates and Forecasts
1.4.1 Global Iopromide Injection Revenue 2020-2031
1.4.2 Global Iopromide Injection Sales 2020-2031
1.4.3 Global Iopromide Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Iopromide Injection Market Competition by Manufacturers
2.1 Global Iopromide Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Iopromide Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Iopromide Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Iopromide Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Iopromide Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Iopromide Injection, Product Type & Application
2.7 Global Key Manufacturers of Iopromide Injection, Date of Enter into This Industry
2.8 Global Iopromide Injection Market Competitive Situation and Trends
2.8.1 Global Iopromide Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Iopromide Injection Players Market Share by Revenue
2.8.3 Global Iopromide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Iopromide Injection Market Scenario by Region
3.1 Global Iopromide Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Iopromide Injection Sales by Region: 2020-2031
3.2.1 Global Iopromide Injection Sales by Region: 2020-2025
3.2.2 Global Iopromide Injection Sales by Region: 2026-2031
3.3 Global Iopromide Injection Revenue by Region: 2020-2031
3.3.1 Global Iopromide Injection Revenue by Region: 2020-2025
3.3.2 Global Iopromide Injection Revenue by Region: 2026-2031
3.4 North America Iopromide Injection Market Facts & Figures by Country
3.4.1 North America Iopromide Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Iopromide Injection Sales by Country (2020-2031)
3.4.3 North America Iopromide Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Iopromide Injection Market Facts & Figures by Country
3.5.1 Europe Iopromide Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Iopromide Injection Sales by Country (2020-2031)
3.5.3 Europe Iopromide Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Iopromide Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Iopromide Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Iopromide Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Iopromide Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Iopromide Injection Market Facts & Figures by Country
3.7.1 Latin America Iopromide Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Iopromide Injection Sales by Country (2020-2031)
3.7.3 Latin America Iopromide Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Iopromide Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Iopromide Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Iopromide Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Iopromide Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Iopromide Injection Sales by Type (2020-2031)
4.1.1 Global Iopromide Injection Sales by Type (2020-2025)
4.1.2 Global Iopromide Injection Sales by Type (2026-2031)
4.1.3 Global Iopromide Injection Sales Market Share by Type (2020-2031)
4.2 Global Iopromide Injection Revenue by Type (2020-2031)
4.2.1 Global Iopromide Injection Revenue by Type (2020-2025)
4.2.2 Global Iopromide Injection Revenue by Type (2026-2031)
4.2.3 Global Iopromide Injection Revenue Market Share by Type (2020-2031)
4.3 Global Iopromide Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Iopromide Injection Sales by Application (2020-2031)
5.1.1 Global Iopromide Injection Sales by Application (2020-2025)
5.1.2 Global Iopromide Injection Sales by Application (2026-2031)
5.1.3 Global Iopromide Injection Sales Market Share by Application (2020-2031)
5.2 Global Iopromide Injection Revenue by Application (2020-2031)
5.2.1 Global Iopromide Injection Revenue by Application (2020-2025)
5.2.2 Global Iopromide Injection Revenue by Application (2026-2031)
5.2.3 Global Iopromide Injection Revenue Market Share by Application (2020-2031)
5.3 Global Iopromide Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer HealthCare
6.1.1 Bayer HealthCare Company Information
6.1.2 Bayer HealthCare Description and Business Overview
6.1.3 Bayer HealthCare Iopromide Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer HealthCare Iopromide Injection Product Portfolio
6.1.5 Bayer HealthCare Recent Developments/Updates
6.2 Brilliant Pharmaceutical
6.2.1 Brilliant Pharmaceutical Company Information
6.2.2 Brilliant Pharmaceutical Description and Business Overview
6.2.3 Brilliant Pharmaceutical Iopromide Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Brilliant Pharmaceutical Iopromide Injection Product Portfolio
6.2.5 Brilliant Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Iopromide Injection Industry Chain Analysis
7.2 Iopromide Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Iopromide Injection Production Mode & Process Analysis
7.4 Iopromide Injection Sales and Marketing
7.4.1 Iopromide Injection Sales Channels
7.4.2 Iopromide Injection Distributors
7.5 Iopromide Injection Customer Analysis
8 Iopromide Injection Market Dynamics
8.1 Iopromide Injection Industry Trends
8.2 Iopromide Injection Market Drivers
8.3 Iopromide Injection Market Challenges
8.4 Iopromide Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Iopromide Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Iopromide Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Iopromide Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Iopromide Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Iopromide Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Iopromide Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Iopromide Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Iopromide Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Iopromide Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Iopromide Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Iopromide Injection, Product Type & Application
Table 12. Global Key Manufacturers of Iopromide Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Iopromide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iopromide Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Iopromide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Iopromide Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Iopromide Injection Sales Market Share by Region (2020-2025)
Table 19. Global Iopromide Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Iopromide Injection Sales Market Share by Region (2026-2031)
Table 21. Global Iopromide Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Iopromide Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Iopromide Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Iopromide Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Iopromide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Iopromide Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Iopromide Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Iopromide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Iopromide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Iopromide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Iopromide Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Iopromide Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Iopromide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Iopromide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Iopromide Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Iopromide Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Iopromide Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Iopromide Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Iopromide Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Iopromide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Iopromide Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Iopromide Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Iopromide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Iopromide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Iopromide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Iopromide Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Iopromide Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Iopromide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Iopromide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Iopromide Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Iopromide Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Iopromide Injection Sales Market Share by Type (2020-2025)
Table 53. Global Iopromide Injection Sales Market Share by Type (2026-2031)
Table 54. Global Iopromide Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Iopromide Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Iopromide Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Iopromide Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Iopromide Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Iopromide Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Iopromide Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Iopromide Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Iopromide Injection Sales Market Share by Application (2020-2025)
Table 63. Global Iopromide Injection Sales Market Share by Application (2026-2031)
Table 64. Global Iopromide Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Iopromide Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Iopromide Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Iopromide Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Iopromide Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Iopromide Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Bayer HealthCare Company Information
Table 71. Bayer HealthCare Description and Business Overview
Table 72. Bayer HealthCare Iopromide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Bayer HealthCare Iopromide Injection Product
Table 74. Bayer HealthCare Recent Developments/Updates
Table 75. Brilliant Pharmaceutical Company Information
Table 76. Brilliant Pharmaceutical Description and Business Overview
Table 77. Brilliant Pharmaceutical Iopromide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Brilliant Pharmaceutical Iopromide Injection Product
Table 79. Brilliant Pharmaceutical Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Iopromide Injection Distributors List
Table 83. Iopromide Injection Customers List
Table 84. Iopromide Injection Market Trends
Table 85. Iopromide Injection Market Drivers
Table 86. Iopromide Injection Market Challenges
Table 87. Iopromide Injection Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report


List of Figures
Figure 1. Product Picture of Iopromide Injection
Figure 2. Global Iopromide Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Iopromide Injection Market Share by Type: 2024 & 2031
Figure 4. 150 mg I/mL Product Picture
Figure 5. 240 mg I/mL Product Picture
Figure 6. 300 mg I/mL Product Picture
Figure 7. 370 mg I/mL Product Picture
Figure 8. Global Iopromide Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Iopromide Injection Market Share by Application: 2024 & 2031
Figure 10. CT
Figure 11. Digital Subtraction Angiography
Figure 12. Other
Figure 13. Global Iopromide Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Iopromide Injection Market Size (2020-2031) & (US$ Million)
Figure 15. Global Iopromide Injection Sales (2020-2031) & (K Units)
Figure 16. Global Iopromide Injection Average Price (US$/Unit) & (2020-2031)
Figure 17. Iopromide Injection Report Years Considered
Figure 18. Iopromide Injection Sales Share by Manufacturers in 2024
Figure 19. Global Iopromide Injection Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Iopromide Injection Players: Market Share by Revenue in Iopromide Injection in 2024
Figure 21. Iopromide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Iopromide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Iopromide Injection Sales Market Share by Country (2020-2031)
Figure 24. North America Iopromide Injection Revenue Market Share by Country (2020-2031)
Figure 25. United States Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Iopromide Injection Sales Market Share by Country (2020-2031)
Figure 28. Europe Iopromide Injection Revenue Market Share by Country (2020-2031)
Figure 29. Germany Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Iopromide Injection Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Iopromide Injection Revenue Market Share by Region (2020-2031)
Figure 36. China Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Iopromide Injection Sales Market Share by Country (2020-2031)
Figure 44. Latin America Iopromide Injection Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Iopromide Injection Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Iopromide Injection Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Iopromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Iopromide Injection by Type (2020-2031)
Figure 54. Global Revenue Market Share of Iopromide Injection by Type (2020-2031)
Figure 55. Global Iopromide Injection Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Iopromide Injection by Application (2020-2031)
Figure 57. Global Revenue Market Share of Iopromide Injection by Application (2020-2031)
Figure 58. Global Iopromide Injection Price (US$/Unit) by Application (2020-2031)
Figure 59. Iopromide Injection Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies